Literature DB >> 9655214

Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.

J W Chung1, T H Yoon.   

Abstract

Cholesteatomatous bone destruction is caused by an increase in collagenase activity and activation of the osteoclasts. Cytokines. such as interleukins (IL), are important in intercellular communication in the mechanism of bone destruction. Middle ear cholesteatomas and external auditory canal skins (EACS) can be surgically obtained and cultured. The quantities of IL-1alpha, IL-1beta and IL-8 secretions were measured in the supernatant of each culture series. On the 2nd day of culture, the level of IL-1alpha was 0.60+/-0.13 (pg/microg of total protein) in cholesteatoma, and 0.25+/-0.02 in EACS. The levels of IL-1beta in cholesteatoma and EACS were 0.41+/-0.06 and 0.24+/-0.02, respectively. The levels of IL-8 in cholesteatoma and EACS were 146.50+/-32.37 and 50.40+/-6.24, respectively. After 2 days, the levels of IL-1alpha and IL-8 of each tissue decreased. The value from fibroblasts did not show a significant difference between cholesteatoma and EACS, and the values did not change as time passed. We can conclude that the IL-1alpha and IL-8 from the cholesteatomatous epithelium are responsible for the cholesteatomatous bone destruction and certain substances from the subepithelial granulation tissue can stimulate the cholesteatoma to produce IL-1alpha and IL-8.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655214     DOI: 10.1080/00016489850183485

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  9 in total

1.  EGFR expression in acquired middle ear cholesteatoma in children and adults.

Authors:  Adriana Leal Alves; Celina Siqueira Barbosa Pereira; Maria de Fatima Pereira Carvalho; Jose Humberto Tavares Guerreiro Fregnani; Fernando Quintanilha Ribeiro
Journal:  Eur J Pediatr       Date:  2011-07-29       Impact factor: 3.183

2.  Lateral semicircular canal fistula in cholesteatoma: diagnosis and management.

Authors:  Anais Meyer; Pierre Bouchetemblé; Bertrand Costentin; Danièle Dehesdin; Yannick Lerosey; Jean-Paul Marie
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-09-08       Impact factor: 2.503

3.  Cholesteatoma fibroblasts promote epithelial cell proliferation through overexpression of epiregulin.

Authors:  Mamoru Yoshikawa; Hiromi Kojima; Yuichiro Yaguchi; Naoko Okada; Hirohisa Saito; Hiroshi Moriyama
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 4.  Updates and knowledge gaps in cholesteatoma research.

Authors:  Chin-Lung Kuo; An-Suey Shiao; Matthew Yung; Masafumi Sakagami; Holger Sudhoff; Chih-Hung Wang; Chyong-Hsin Hsu; Chiang-Feng Lien
Journal:  Biomed Res Int       Date:  2015-03-18       Impact factor: 3.411

Review 5.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

6.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

7.  Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?

Authors:  Mohammed Hassan Hussain; Manish Mair; Sara Mahmood; Georgios Sakagiannis; Djamila M Rojoa; Firas J Raheman; Esmee Irvine; Peter Rea
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-10       Impact factor: 2.503

Review 8.  The role of tumor necrosis factor-alpha (TNF-alpha) in bone resorption present in middle ear cholesteatoma.

Authors:  Rodrigo Faller Vitale; Fernando de Andrade Quintanilha Ribeiro
Journal:  Braz J Otorhinolaryngol       Date:  2007 Jan-Feb

9.  Analysis of histopathological aspects in acquired middle ear cholesteatoma.

Authors:  Adriana Leal Alves; Celina Siqueira Barbosa Pereira; Fernando de Andrade Quintanilha Ribeiro; Jose Humberto Tavares Guerreiro Fregnani
Journal:  Braz J Otorhinolaryngol       Date:  2008 Nov-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.